Wanbangde Pharmaceutical Holding Group Co Ltd (002082) — Financial Flexibility Index
Wanbangde Pharmaceutical Holding Group Co Ltd (002082) has a Financial Flexibility Index of 0.08x as of September 2025. Free cash flow of CN¥144.78 Million (operating CF CN¥-1.04 Million minus capex CN¥145.81 Million) represents 0% of total liabilities (CN¥1.78 Billion). Also explore 002082 shareholders equity momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Wanbangde Pharmaceutical Holding Group Co Ltd Financial Flexibility Index (2003–2025)
Historical Financial Flexibility Index trend for Wanbangde Pharmaceutical Holding Group Co Ltd across 23 annual periods. Check 002082 capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Wanbangde Pharmaceutical Holding Group Co Ltd (2003–2025)
Year-by-year free cash flow to debt coverage for Wanbangde Pharmaceutical Holding Group Co Ltd. For the full company profile including market capitalisation, see Wanbangde Pharmaceutical Holding Group C market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.50x | CN¥893.63 Million | CN¥603.98 Million | CN¥1.78 Billion | ▲ +277.2% |
| 2024 | 0.13x | CN¥208.65 Million | CN¥120.22 Million | CN¥1.57 Billion | ▲ +265.6% |
| 2023 | 0.04x | CN¥55.85 Million | CN¥-72.87 Million | CN¥1.54 Billion | ▲ +170.1% |
| 2022 | -0.05x | CN¥-72.42 Million | CN¥-239.65 Million | CN¥1.40 Billion | ▼ -128.2% |
| 2021 | 0.18x | CN¥299.14 Million | CN¥22.09 Million | CN¥1.63 Billion | ▼ -27.4% |
| 2020 | 0.25x | CN¥710.25 Million | CN¥151.01 Million | CN¥2.80 Billion | ▲ +204.1% |
| 2019 | 0.08x | CN¥157.29 Million | CN¥-248.69 Million | CN¥1.89 Billion | ▼ -72.1% |
| 2018 | 0.30x | CN¥335.03 Million | CN¥135.40 Million | CN¥1.12 Billion | ▲ +4424.1% |
| 2017 | 0.01x | CN¥3.28 Million | CN¥-17.60 Million | CN¥496.58 Million | ▼ -99.5% |
| 2016 | 1.22x | CN¥319.74 Million | CN¥310.71 Million | CN¥261.85 Million | ▲ +598.8% |
| 2015 | 0.17x | CN¥47.23 Million | CN¥16.76 Million | CN¥270.28 Million | ▼ -76.0% |
| 2014 | 0.73x | CN¥185.22 Million | CN¥140.31 Million | CN¥254.69 Million | ▲ +6.4% |
| 2013 | 0.68x | CN¥246.80 Million | CN¥234.35 Million | CN¥361.07 Million | ▲ +31.6% |
| 2012 | 0.52x | CN¥243.65 Million | CN¥202.73 Million | CN¥469.09 Million | ▲ +53.3% |
| 2011 | 0.34x | CN¥132.86 Million | CN¥-1.44 Million | CN¥392.22 Million | ▼ -37.5% |
| 2010 | 0.54x | CN¥206.29 Million | CN¥162.26 Million | CN¥380.46 Million | ▲ +30.1% |
| 2009 | 0.42x | CN¥128.15 Million | CN¥68.13 Million | CN¥307.39 Million | ▼ -67.7% |
| 2008 | 1.29x | CN¥399.99 Million | CN¥253.06 Million | CN¥309.46 Million | ▲ +442.4% |
| 2007 | 0.24x | CN¥122.13 Million | CN¥12.45 Million | CN¥512.51 Million | ▲ +21.4% |
| 2006 | 0.20x | CN¥96.97 Million | CN¥3.50 Million | CN¥493.85 Million | ▲ +0.8% |
| 2005 | 0.19x | CN¥99.08 Million | CN¥11.23 Million | CN¥508.84 Million | ▼ -58.3% |
| 2004 | 0.47x | CN¥130.99 Million | CN¥32.69 Million | CN¥280.48 Million | ▲ +1.6% |
| 2003 | 0.46x | CN¥74.93 Million | CN¥37.01 Million | CN¥163.05 Million | — |